Paromomycin: No More Effective than Placebo for Treatment of Cryptosporidiosis in Patients with Advanced Human Immunodeficiency Virus Infection

Clicks: 3
ID: 272546
2000
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1,077 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract. To evaluate the efficacy of paromomycin for the treatment of symptomatic cryptosporidial enteritis in human immunodeficiency virus-infected adults, we
Reference Key
g.2000clinicalparomomycin: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hewitt, Ross G.;Yiannoutsos, Constantin T.;Higgs, Elizabeth S.;Carey, John T.;Geiseler, P. Jan;Soave, Rosemary;Rosenberg, Richard;Vazquez, Guillermo J.;Wheat, L. Joseph;Fass, Robert J.;Antoninievic, Zoran;Walawander, Ann L.;Flanigan, Timothy P.;Bender, John F.;
Journal clinical infectious diseases
Year 2000
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.